H-EMTPVNPG-OH

Ref. 3D-PP45276

Informations sur le produit

• Nom: H-EMTPVNPG-OH
• Synonymes: NH2-Glu-Met-Thr-Pro-Val-Asn-Pro-Gly-OH

Description

Peptide H-EMTPVNPG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EMTPVNPG-OH include the following: AFP peptide (AFPep) as a potential growth factor for prostate cancer Z Zhu, GR West, DC Wang, AB Collins, H Xiao , Q Bai - Medical Oncology, 2022 - Springerhttps://link.springer.com/article/10.1007/s12032-021-01598-4 Peptides with dual antimicrobial-anticancer activity: Strategies to overcome peptide limitations and rational design of anticancer peptides Y Liscano , J Oaca±ate-Garzon, JP Delgado - Molecules, 2020 - mdpi.comhttps://www.mdpi.com/1420-3049/25/18/4245 Gravidomimetic Prevention of Breast Cancer TT Andersen, HI Jacobson, JA Bennett, L DeFreest - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA406139 Breast Cancer Research Undergraduate Summer Training Program TT Andersen, ALBANY MEDICAL COLL NY - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA425791 Targeted drug delivery for breast cancer treatment S Jin , K Ye - Recent patents on anti-cancer drug discovery, 2013 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/pra/2013/00000008/00000002/art00003 Mutation Based Structural Modelling and Dynamics Study of Alpha Fetoprotein: An Insight to Inhibitory Mechanism in Breast Cancer P Patel , PK Panda , S Patil , H Panchal - J Proteomics Bioinform, 2018 - academia.eduhttps://www.academia.edu/download/74945080/jpb.pdf Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein LC Joseph, JA Bennett, KN Kirschner - European Peptide , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.1119 Second Generation Analogs of the Anticancer Peptide AFPep: Enhancement of Efficacy and Dose Range LC Joseph - 2009 - search.proquest.comhttps://search.proquest.com/openview/2074c90a09139f5172da911ed40f163b/1?pq-origsite=gscholar&cbl=18750 Identification of Cellular Binding Sites for a Novel LA DeFreest, JA Bennett, ALBANY MEDICAL COLL NY - 2005 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA437620 The search for low energy conformational families of small peptides: Searching for active conformations of small peptides in the absence of a known receptor KW Lexa , KA Alser, AM Salisburg - Journal of Quantum , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/qua.21449 Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein KN Kirschner , KW Lexa , AM Salisburg - Journal of the , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja070202w Quantification of a novel anti-breast cancer cyclic peptide (AFPep) in serum using liquid chromatography coupled with mass spectrometry and its application in JMW Zhu, TT Andersen, JA Bennett - Curr. Top. Pept , 2017 - researchgate.nethttps://www.researchgate.net/profile/Qishan-Lin/publication/324598017_2017pk_paper/links/5ad7b97b458515c60f588b76/2017pk-paper.pdf A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen JA Bennett, FB Mesfin, TT Andersen - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.251667098 Development of an active site peptide analog of alpha-fetoprotein that prevents breast cancer HI Jacobson, TT Andersen, JA Bennett - Cancer Prevention Research, 2014 - AACRhttps://aacrjournals.org/cancerpreventionresearch/article-abstract/7/6/565/50293 Exploiting for Breast Cancer Control a Proposed Unified Mechanism for Reduction of Human Breast Cancer Risk by the Hormones of Pregnancy H Jacobson, TT Andersen, JA Bennett - 2005 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA473791 alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics GJ Mizejewski, R MacColl - Molecular cancer therapeutics, 2003 - AACRhttps://aacrjournals.org/mct/article-abstract/2/11/1243/234101 The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins GJ Mizejewski - Tumor Biology, 2016 - Springerhttps://link.springer.com/article/10.1007/s13277-016-5131-x The Alpha-Fetoprotein-Derived Growth Inhibitory Peptide 8-Mer Fragment: Review of a Novel Anticancer Agent GJ Mizejewski - Cancer biotherapy & radiopharmaceuticals, 2007 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/cbr.2006.343 Computational approaches for the design of peptides with anti-breast cancer properties GC Shields - 2009 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/fmc.09.13 Peptides targeting estrogen receptor alpha-potential applications for breast cancer treatment G Leclercq, D Gallo, J Cossy, I Laios - Current , 2011 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2011/00000017/00000025/art00006 Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer FB Mesfin, S Zhu, JA Bennett - Journal of Peptide , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-3011.2001.00922.x Alpha-fetoprotein-derived antiestrotrophic octapeptide FB Mesfin, JA Bennett, HI Jacobson, SJ Zhu - et Biophysica Acta (BBA , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0925443900000089 Design, synthesis, and characterization of anti-estrogenic and anti-breast cancer alpha-fetoprotein-derived peptides FB Mesfin - 2001 - search.proquest.comhttps://search.proquest.com/openview/c53e12a9b862a0d51b3bb605a20c5add/1?pq-origsite=gscholar&cbl=18750&diss=y AFP-Derived Peptides Which Stop Breast Cancer Growth F Mesfin, TT Anderson, JA Bennett - 2000., 2000 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA396385 Solid-phase organic synthesis (SPOS) of modulators of estrogenic and androgenic action D Poirier , R Maltais - Mini Reviews in Medicinal Chemistry, 2006 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/mrmc/2006/00000006/00000001/art00005 Journal â„– 5 for 2012 г. Article in number: AFP-derived octapeptide is a promising peptide vehicle for targeted delivery of cytostatic agent into tumor cells AV Bereznikova, GA Posypanova, VA Makarov - radiotec.ruhttp://radiotec.ru/en/journal/19/number/2012-5/article/10936 Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides aca Roxin , G Zheng - Future medicinal chemistry, 2012 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/fmc.12.75 Use of anticancer peptides as an alternative approach for targeted therapy in breast cancer: a review A Orafaie , AR Bahrami , MM Matin - Nanomedicine, 2021 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/nnm-2020-0352 Plausible interaction of an alpha-fetoprotein cyclopeptide with the G-protein-coupled receptor model GPR30: docking study by molecular dynamics simulated A Hamza, MH Sarma, RH Sarma - Journal of Biomolecular , 2003 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2003.10506892 Design and synthesis of biologically active peptides: a 'tail'of amino acids can modulate activity of synthetic cyclic peptides A Bryan, L Joseph, JA Bennett, HI Jacobson - Peptides, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978111004141

• Marque: Biosynth